Brigitte Neuber

Heidelberg, BW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications

Impaired hematopoiesis affects apheresis and CAR T-cell product composition and treatment response.

Impaired hematopoiesis affects apheresis and CAR T-cell product composition and treatment response.

Journal: Transfusion
Published: December 17, 2025

Third-generation anti-CD19 CAR T cells for relapsed/refractory chronic lymphocytic leukemia: a phase 1/2 study.

Third-generation anti-CD19 CAR T cells for relapsed/refractory chronic lymphocytic leukemia: a phase 1/2 study.

Journal: Leukemia
Published: June 23, 2024

Proteasome inhibition enhances the anti-leukemic efficacy of chimeric antigen receptor (CAR) expressing NK cells against acute myeloid leukemia.

Proteasome inhibition enhances the anti-leukemic efficacy of chimeric antigen receptor (CAR) expressing NK cells against acute myeloid leukemia.

Journal: Journal of hematology & oncology
Published: April 18, 2024

PD-1 checkpoint inhibition enhances the antilymphoma activity of CD19-CAR-iNKT cells that retain their ability to prevent alloreactivity.

PD-1 checkpoint inhibition enhances the antilymphoma activity of CD19-CAR-iNKT cells that retain their ability to prevent alloreactivity.

Journal: Journal for immunotherapy of cancer
Published: December 21, 2023

Extracorporeal photopheresis as a promising strategy for the treatment of graft-versus-host disease after CAR T-cell therapy.

Extracorporeal photopheresis as a promising strategy for the treatment of graft-versus-host disease after CAR T-cell therapy.

Journal: Blood advances
Published: December 20, 2023

In Vitro Functionality and Endurance of GMP-Compliant Point-of-Care BCMA.CAR-T Cells at Different Timepoints of Cryopreservation.

In Vitro Functionality and Endurance of GMP-Compliant Point-of-Care BCMA.CAR-T Cells at Different Timepoints of Cryopreservation.

Journal: International journal of molecular sciences
Published: December 10, 2023

Treatment of adult ALL patients with third-generation CD19-directed CAR T cells: results of a pivotal trial.

Treatment of adult ALL patients with third-generation CD19-directed CAR T cells: results of a pivotal trial.

Journal: Journal of hematology & oncology
Published: February 28, 2023

Impact of serum‑free media on the expansion and functionality of CD19.CAR T‑cells.

Impact of serum‑free media on the expansion and functionality of CD19.CAR T‑cells.

Journal: International journal of molecular medicine
Published: February 13, 2023

Individualised immunosuppression with intravenously administered donor-derived modified immune cells compared with standard of care in living donor kidney transplantation (TOL-2 Study): protocol for a multicentre, open-label, phase II, randomised controlled trial.

Individualised immunosuppression with intravenously administered donor-derived modified immune cells compared with standard of care in living donor kidney transplantation (TOL-2 Study): protocol for a multicentre, open-label, phase II, randomised controlled trial.

Journal: BMJ open
Published: November 11, 2022

Definition and Characterization of SOX11-Derived T Cell Epitopes towards Immunotherapy of Glioma.

Definition and Characterization of SOX11-Derived T Cell Epitopes towards Immunotherapy of Glioma.

Journal: International journal of molecular sciences
Published: July 26, 2022

HDAC Inhibition for Optimized Cellular Immunotherapy of NY-ESO-1-Positive Soft Tissue Sarcoma.

HDAC Inhibition for Optimized Cellular Immunotherapy of NY-ESO-1-Positive Soft Tissue Sarcoma.

Journal: Biomedicines
Published: January 12, 2022

Comparison of FACS and PCR for Detection of BCMA-CAR-T Cells.

Comparison of FACS and PCR for Detection of BCMA-CAR-T Cells.

Journal: International journal of molecular sciences
Published: December 23, 2021
Showing 1-12 of 39

Last Updated: 09/26/2026